Related Experiment Video
Updated: Jun 4, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
[Surgical treatment for advanced gastric cancer]
1Department of Gastrointestinal Surgery, Guangdong Provincial Hospital, Guangzhou 510080, China. sylf3133@21cn.com
Abstract:
Despite the incidence of gastric cancer is decreasing, it remains the fourth most common malignancy and the second leading cause of cancer-related death around the world. The prognosis of gastric cancer is still poor and surgery is the mainstay treatment. Lymph node dissection plays an important role in the surgery of gastric cancer due to the high incidence of lymph node metastasis and recurrence. There has been a consensus between the West and the East that D2 lymph node dissection is the standard dissection for advanced gastric cancer. Some clinical trials have showed good results of neoadjuvant chemotherapy in advanced gastric cancer. Large sample randomized controlled studies are needed to confirm the value of neoadjuvant chemotherapy.
Insights
Gastric cancer remains a major global health threat. While surgery with D2 lymph node dissection is standard for advanced cases, neoadjuvant chemotherapy shows promise, requiring further large-scale studies for confirmation.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Gastric cancer is a leading cause of cancer death globally, despite declining incidence.
- Surgery, particularly with D2 lymph node dissection, is the primary treatment for advanced gastric cancer.
- Lymph node metastasis and recurrence are significant challenges in gastric cancer management.
Discussion:
- D2 lymph node dissection is the established standard surgical approach for advanced gastric cancer worldwide.
- Neoadjuvant chemotherapy is being investigated as a potentially beneficial treatment strategy.
- Clinical trials suggest positive outcomes for neoadjuvant chemotherapy in advanced gastric cancer patients.
Key Insights:
- The importance of lymph node dissection in gastric cancer surgery is well-recognized.
- Neoadjuvant chemotherapy is emerging as a promising therapeutic option for advanced gastric cancer.
- Standardization of D2 lymph node dissection is crucial for effective surgical management.
Outlook:
- Further large-scale randomized controlled studies are essential to validate the efficacy of neoadjuvant chemotherapy.
- Continued research into optimizing surgical techniques and neoadjuvant therapies is needed.
- Improving survival rates for gastric cancer patients remains a critical goal in oncology.
More Related Videos
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

